Stempoint Capital’s EyePoint Inc EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
338,471
-472,293
-58% -$6.32M 0.83% 37
2026
Q1
$10.5M Buy
810,764
+456,915
+129% +$6.83M 2% 14
2025
Q4
$6.46M Buy
+353,849
New +$5.01M 1.11% 28
2025
Q3
Sell
-329,254
Closed -$3.1M 89
2025
Q2
$3.1M Buy
+329,254
New +$2.27M 0.99% 30
2025
Q1
Sell
-579,500
Closed -$4.32M 67
2024
Q4
$4.32M Buy
+579,500
New +$5.39M 1.08% 31
2024
Q1
Sell
-95,732
Closed -$2.21M 73
2023
Q4
$2.21M Buy
+95,732
New +$1.07M 0.59% 48

Other funds holding EYPT

Stempoint Capital's EYPT Position: Q2 2026 in Review

Stempoint Capital reduced its EyePoint Inc (EYPT) stake by 58% in Q2 2026, selling an estimated $6.32M and leaving 338,471 shares worth $4.84M. The position accounts for 0.83% of the portfolio, ranked #37.

Stempoint Capital first reported a position in EYPT in Q4 2023 and has held it in 6 quarters since. The position peaked at $10.5M in Q1 2026. 189 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

  • Stempoint Capital held 338,471 shares of EyePoint Inc worth $4.84M as of Q2 2026.
  • Stempoint Capital sold 472,293 EyePoint Inc shares in Q2 2026, an estimated $6.32M.
  • EyePoint Inc made up 0.83% of Stempoint Capital's portfolio in Q2 2026, its #37 holding.
  • Stempoint Capital first reported a position in EyePoint Inc in Q4 2023 and has held it in 6 quarters since.
  • Stempoint Capital's EyePoint Inc position peaked at $10.5M in Q1 2026.
  • 189 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.